drugset / Trial / NCT01058512
A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to find out the effect of the investigational drug NOV-205 on the level of hepatitis C virus in the blood and whether NOV-205 is well-tolerated at different doses when taken by subjects with hepatitis C.
Timeline
- Start
- 2010-03
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NOV-205 | Unknown | 30 mg | Subcutaneous |
| Subject | NOV-205 | Unknown | 60 mg | Subcutaneous |